|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Anebulo Pharmaceuticals (NASDAQ: ANEB) through any online brokerage.
The latest price target for Anebulo Pharmaceuticals (NASDAQ: ANEB) was reported by Benchmark on May 25, 2021. The analyst firm set a price target for 15.00 expecting ANEB to rise to within 12 months (a possible 121.57% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Anebulo Pharmaceuticals (NASDAQ: ANEB) is $6.77 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Anebulo Pharmaceuticals.
Anebulo Pharmaceuticals’s $Q1 earnings are confirmed for after-market on $January 3, 2022.
There is no upcoming split for Anebulo Pharmaceuticals.
Anebulo Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.